Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
P/S (TTM)
0.1
EV / FCF (TTM)
66.6
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
corporate.walgreens.comNo one on the platform currently holds WBA.
No tracked institution reports a position in WBA as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2024-11-18 | $0.2500 | 2024-12-12 |
| 2024-08-21 | $0.2500 | 2024-09-12 |
| 2024-05-20 | $0.2500 | 2024-06-12 |
| 2024-02-16 | $0.2500 | 2024-03-12 |
| 2023-11-13 | $0.4800 | 2023-12-12 |
No one on the platform has traded WBA yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 6.2% | 4.2% | ||||
| Profit Margin % | -5.8% | -0.5% | 1.6% | |||
| Free Cash Flow Margin % | -0.2% | 1.6% | 3.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +8.3% on the P/E track.
At today's price, your expected annual return is +12.3% on the P/E track.
At today's price, your expected annual return is +16.4% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $158.5B | +1.6% | $1.67 | $-0.37–$2.78 | 7.2× | 3 |
| 2028 | $169.8B | +7.1% | $1.80 | $1.66–$1.99 | 6.7× | 2 |
| 2029 | $169.6B | -0.1% | $1.95 | $1.80–$2.15 | 6.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-10-21 | $0.27 | $0.39 | +44.4% |
| 2025-06-26 | $0.33 | $0.38 | +16.1% |
| 2025-04-08 | $0.54 | $0.63 | +17.8% |
| 2025-01-10 | $0.37 | $0.51 | +37.8% |
| 2024-10-15 | $0.36 | $0.39 | +8.8% |
| 2024-06-27 | $0.68 | $0.63 | -7.5% |
| 2024-03-28 | $0.82 | $1.20 | +46.5% |
| 2024-01-04 | $0.63 | $0.66 | +4.8% |
| $223M |
| — |
| KHCThe Kraft Heinz Company | $24.73 | +1.90% | $29.3B | — |
| MMM3M Company | $164.66 | +1.63% | $84.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
$NKE $WBA way more sheep than i could ever convince with my 7100 🚀 rippers, smh. Lies, and nobody calls out. How did you know they would remove WBA from Dow at the time when WBA was even in the DOW. 🤡 🤡 🤡. Blocked.
View on StockTwits ↗
$NKE I #predict Nike is getting removed from the Dow Jones 📉 #DowjonesRemoval I predicted the removal of $WBA a decade ago
View on StockTwits ↗
@moneytrader2017 Thanks. I no longer subscribe to that sentiment though, the main risk being a take-under. I never sold my $WBA shares but they were forcefully stripped away from me at $12. M&A below your basis is a risk, I've lost dearly on it, so you do have to mind the degree of unrealized losses you're sitting on at any given point. I do agree that everything isn't always straight upward though, so it's a balancing act in practice. Down over 50% isn't a great place to be regardless.
View on StockTwits ↗
$WBA approaching one year from take private date. Dap worth less and less each day with double digit interest rates accrued to Walgreens. They should just cancel the dap already
View on StockTwits ↗
$PZZA Going to 8 - 12 then a 14 buyout like $WBA. Same play book.
View on StockTwits ↗
$WBA $SPY $QQQ “I demand you allow us to continue to steal and loot 💩 from your store. How dare you!”
View on StockTwits ↗
$PAYO so with motley fool article today I see both parties agreed to 2.75 billion.. unless it’s ai slop “Roughly one week after takeover buzz about Nuvei acquiring Payoneer for $2.7 billion originally hit the press, the two companies agreed to a $2.75 billion deal, confirming the rumors” so at least current price being 2.36 billion, only .34 billion arbitrage. Looks like this is it for the juice, sell your shares and move on. Wife still has shares of $WBA that $BULL wont convert to cash for her because she held through the end date.
View on StockTwits ↗
$WBA has failed its shareholders, employees, and loyal customers. After years of taking people’s money and relying on hardworking employees, leadership has left many people burned while executives and private equity interests continue to benefit. Shareholders deserve accountability. Employees deserve respect. Customers deserve better. People need to stop being “cowards” and speak up. Demand transparency, demand results, and demand consequences for poor leadership. Stand for something, or keep watching these companies take everything while giving nothing back.
View on StockTwits ↗
$WBA isn't there some sort of extra payment due or could be due here for previous stock holders? If yes, please explain. TYIA
View on StockTwits ↗
$ADBE $BRK.B $PYPL so your like everyone else, you got winners and always that loser. In this case it’s PayPal, which I think might be the loser of the decade. $WBA as well
View on StockTwits ↗
If you missed the deadline, don’t miss this update. You may still be able to recover losses from $WBA— late claims are currently being accepted: https://11th.com/cases/walgreen-shareholder-settlement This recovery fund was established after claims that Walgreens deceived investors about business prospects. Even though the official deadline has passed, the court is still accepting late submissions. Who can apply? If you bought or held $WBA between April 17, 2014, and August 5, 2014, you’re likely eligible — even if you already sold your shares.
View on StockTwits ↗$WBA stole their investors money then has the audacity!
View on StockTwits ↗
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.